Aldose reductase inhibition by spiro indoline derivatives
US4581366A · kind A · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 1984 |
| Grant date | Apr 8, 1986 |
| Priority date | — |
| Expiry date | Mar 19, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/38
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention concerns 1'-(4-bromo-2-fluorobenzyl)-7'-chloro-spiro[imidazolidine-4,3'-indoline]-2 ,2',5-trione in racemic or dextrorotatory form; pharmaceutical compositions thereof for use in the treatment or prophylaxis of certain complications of diabetes; and processes for its manufacture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.